logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 8
  • 1
    Tadeusz Czernuszka, Jan, Professor
    Academic born in January 1960
    Individual (3 offsprings)
    Officer
    2017-01-01 ~ 2021-11-09
    OF - Director → CIF 0
  • 2
    Thong, Robert Vee-lin
    Born in January 1961
    Individual (16 offsprings)
    Officer
    2022-02-02 ~ now
    OF - Director → CIF 0
  • 3
    Ashrafian, Hutan, Dr
    Born in September 1975
    Individual (3 offsprings)
    Officer
    2017-01-01 ~ 2026-03-30
    OF - Director → CIF 0
  • 4
    Fitzpatrick, Anthony John, Dr
    Director born in July 1956
    Individual (2 offsprings)
    Officer
    2016-12-17 ~ 2020-02-11
    OF - Director → CIF 0
    Dr Anthony John Fitzpatrick
    Born in July 1956
    Individual (2 offsprings)
    Person with significant control
    2016-12-17 ~ 2020-02-11
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 5
    Jackson, David Edward, Dr
    Consultant born in June 1957
    Individual (9 offsprings)
    Officer
    2019-12-05 ~ 2022-09-20
    OF - Director → CIF 0
  • 6
    Fitzpatrick, Caroline Barbara
    Individual (2 offsprings)
    Officer
    2016-12-17 ~ 2020-02-11
    OF - Secretary → CIF 0
  • 7
    Easter, Camilla, Dr
    Born in February 1988
    Individual (1 offspring)
    Officer
    2019-12-05 ~ now
    OF - Director → CIF 0
  • 8
    Edwards, Nicholas Huw
    Born in June 1961
    Individual (31 offsprings)
    Officer
    2017-01-03 ~ now
    OF - Director → CIF 0
    Dr Nicholas Huw Edwards
    Born in June 1961
    Individual (31 offsprings)
    Person with significant control
    2018-12-19 ~ 2020-10-20
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

OXFORD MEDICAL PRODUCTS LIMITED

Period: 2019-03-15 ~ now
Company number: 10530319
Registered names
OXFORD MEDICAL PRODUCTS LIMITED - now
JAMCOWP01 LIMITED - 2017-01-25
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
132024-10-01 ~ 2025-09-30
152024-01-01 ~ 2024-09-30
Property, Plant & Equipment
695,191 GBP2025-09-30
743,838 GBP2024-09-30
Debtors
Current
649,533 GBP2025-09-30
979,237 GBP2024-09-30
Cash at bank and in hand
219,242 GBP2025-09-30
1,502,825 GBP2024-09-30
Current Assets
868,775 GBP2025-09-30
2,482,062 GBP2024-09-30
Creditors
Current, Amounts falling due within one year
-111,125 GBP2025-09-30
-751,580 GBP2024-09-30
Net Current Assets/Liabilities
757,650 GBP2025-09-30
1,730,482 GBP2024-09-30
Total Assets Less Current Liabilities
1,452,841 GBP2025-09-30
2,474,320 GBP2024-09-30
Creditors
Non-current, Amounts falling due after one year
-4,756,716 GBP2025-09-30
Net Assets/Liabilities
-3,425,079 GBP2025-09-30
-2,114,103 GBP2024-09-30
Equity
Called up share capital
3,010 GBP2025-09-30
2,988 GBP2024-09-30
2,988 GBP2024-01-01
Share premium
4,358,550 GBP2025-09-30
4,078,736 GBP2024-09-30
4,078,736 GBP2024-01-01
Retained earnings (accumulated losses)
-7,786,639 GBP2025-09-30
-6,195,827 GBP2024-09-30
-4,265,612 GBP2024-01-01
Equity
-3,425,079 GBP2025-09-30
-2,114,103 GBP2024-09-30
-183,888 GBP2024-01-01
Profit/Loss
Retained earnings (accumulated losses)
-1,752,536 GBP2024-10-01 ~ 2025-09-30
-1,930,215 GBP2024-01-01 ~ 2024-09-30
Profit/Loss
-1,752,536 GBP2024-10-01 ~ 2025-09-30
-1,930,215 GBP2024-01-01 ~ 2024-09-30
Issue of Equity Instruments
Called up share capital
22 GBP2024-10-01 ~ 2025-09-30
Issue of Equity Instruments
279,836 GBP2024-10-01 ~ 2025-09-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
535,527 GBP2025-09-30
413,803 GBP2024-09-30
Property, Plant & Equipment - Gross Cost
1,053,793 GBP2025-09-30
932,069 GBP2024-09-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
138,728 GBP2024-09-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
188,231 GBP2024-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Owned/Freehold
170,371 GBP2024-10-01 ~ 2025-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
254,177 GBP2025-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
358,602 GBP2025-09-30
Property, Plant & Equipment
Plant and equipment
281,350 GBP2025-09-30
275,075 GBP2024-09-30
Other Debtors
Current
12,934 GBP2025-09-30
109,953 GBP2024-09-30
Prepayments/Accrued Income
Current
35,110 GBP2025-09-30
336,129 GBP2024-09-30
Amount of corporation tax that is recoverable
Current
601,489 GBP2025-09-30
533,155 GBP2024-09-30
Trade Creditors/Trade Payables
Current
43,475 GBP2025-09-30
376,720 GBP2024-09-30
Taxation/Social Security Payable
Current
24,831 GBP2025-09-30
35,128 GBP2024-09-30
Other Creditors
Current
5,121 GBP2025-09-30
9,292 GBP2024-09-30
Accrued Liabilities/Deferred Income
Current
37,698 GBP2025-09-30
330,440 GBP2024-09-30
Creditors
Current
111,125 GBP2025-09-30
751,580 GBP2024-09-30
Bank Borrowings
Non-current
4,756,716 GBP2025-09-30
4,467,219 GBP2024-09-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
220,251 shares2025-09-30
220,251 shares2024-09-30
Par Value of Share
Class 1 ordinary share
0.012024-10-01 ~ 2025-09-30
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
47,487 shares2025-09-30
47,487 shares2024-09-30
Par Value of Share
Class 2 ordinary share
0.012024-10-01 ~ 2025-09-30
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
27,698 shares2025-09-30
27,698 shares2024-09-30
Par Value of Share
Class 3 ordinary share
0.012024-10-01 ~ 2025-09-30
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
5,572 shares2025-09-30
3,376 shares2024-09-30
Par Value of Share
Class 4 ordinary share
0.012024-10-01 ~ 2025-09-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
39,900 GBP2025-09-30
39,900 GBP2024-09-30
Between one and five year
114,672 GBP2025-09-30
154,572 GBP2024-09-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
154,572 GBP2025-09-30
194,472 GBP2024-09-30
  • OXFORD MEDICAL PRODUCTS LIMITED
    Info
    SATIE8 LIMITED - 2019-03-15
    JAMCOWP01 LIMITED - 2019-03-15
    Registered number 10530319
    Unit 3, The Gateway, Windrush Park Road, Witney, Oxfordshire OX29 7EY
    PRIVATE LIMITED COMPANY incorporated on 2016-12-17 (9 years 5 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-02-07
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.